Cash Flow Statement

Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Vsee Health (VSEE) Acquisitions (2024)

Vsee Health filings provide 1 years of Acquisitions readings, the most recent being $29123.0 for Q2 2024.

On a quarterly basis, Acquisitions changed N/A to $29123.0 in Q2 2024 year-over-year; TTM through Jun 2024 was $29123.0, a N/A change, with the full-year FY2024 number at $29123.0, changed N/A from a year prior.
Acquisitions hit $29123.0 in Q2 2024 for Vsee Health.
In the past five years, Acquisitions ranged from a high of $29123.0 in Q2 2024 to a low of $29123.0 in Q2 2024.